Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP847525.RAOjQpCEfVGzCRiL-mc539NfqR7YYEmKMK4Rl4yUI032c130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP847525.RAOjQpCEfVGzCRiL-mc539NfqR7YYEmKMK4Rl4yUI032c130_assertion type Assertion NP847525.RAOjQpCEfVGzCRiL-mc539NfqR7YYEmKMK4Rl4yUI032c130_head.
- NP847525.RAOjQpCEfVGzCRiL-mc539NfqR7YYEmKMK4Rl4yUI032c130_assertion description "[We have found that methylated MGMT, CDKN2A, and MLH1 occur in 49%, 34%, and 7% of adenomas and in 5%, 10%, and 7% of hyperplastic polyps, respectively, and that they are more common in histologically advanced adenomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP847525.RAOjQpCEfVGzCRiL-mc539NfqR7YYEmKMK4Rl4yUI032c130_provenance.
- NP847525.RAOjQpCEfVGzCRiL-mc539NfqR7YYEmKMK4Rl4yUI032c130_assertion evidence source_evidence_literature NP847525.RAOjQpCEfVGzCRiL-mc539NfqR7YYEmKMK4Rl4yUI032c130_provenance.
- NP847525.RAOjQpCEfVGzCRiL-mc539NfqR7YYEmKMK4Rl4yUI032c130_assertion SIO_000772 15709190 NP847525.RAOjQpCEfVGzCRiL-mc539NfqR7YYEmKMK4Rl4yUI032c130_provenance.
- NP847525.RAOjQpCEfVGzCRiL-mc539NfqR7YYEmKMK4Rl4yUI032c130_assertion wasDerivedFrom befree-20140225 NP847525.RAOjQpCEfVGzCRiL-mc539NfqR7YYEmKMK4Rl4yUI032c130_provenance.
- NP847525.RAOjQpCEfVGzCRiL-mc539NfqR7YYEmKMK4Rl4yUI032c130_assertion wasGeneratedBy ECO_0000203 NP847525.RAOjQpCEfVGzCRiL-mc539NfqR7YYEmKMK4Rl4yUI032c130_provenance.